Rand Bioscience Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$2.62M
- Investors
-
8
Rand Bioscience General Information
Description
Developer of drugs designed to make mankind free and happy from disease. The company discovers and evaluates innovative new drugs and global licensing for cancer and immunology therapies, enabling healthcare companies to find new ways to cure various diseases and help patients live healthy lives.
Contact Information
Website
www.randbio.comCorporate Office
- 402, 403. 4th floor, 82 Daehak-ro
- Yuseong-gu, Daejeon- A108
- Daejeon
- South Korea
Corporate Office
- 402, 403. 4th floor, 82 Daehak-ro
- Yuseong-gu, Daejeon- A108
- Daejeon
- South Korea
Rand Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 02-Aug-2021 | $2.62M | Completed | Clinical Trials - Phase 1 | ||
| 2. Early Stage VC (Series A) | 09-May-2019 | Completed | Clinical Trials - Phase 1 | |||
| 1. Seed Round | 04-Jan-2016 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Rand Bioscience Patents
Rand Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2014277262-A1 | A quinoline inhibitor of the macrophage stimulating 1 receptor mst1 r | Active | 06-Jun-2013 | ||
| AU-2014277262-B2 | A quinoline inhibitor of the macrophage stimulating 1 receptor mst1 r | Inactive | 06-Jun-2013 | ||
| CA-2914500-A1 | A quinoline inhibitor of the macrophage stimulating 1 receptor mst1 r | Active | 06-Jun-2013 | ||
| CA-2914500-C | A quinoline inhibitor of the macrophage stimulating 1 receptor mst1 r | Active | 06-Jun-2013 | C07D401/14 |
Rand Bioscience Signals
Rand Bioscience Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ontide | Corporation | Minority | ||
| Shinhan Venture Investment | Venture Capital | Minority | ||
| C&R Research | Corporation | Minority | ||
| Emford Equity Partners | Venture Capital | Minority | ||
| KB Investment | Venture Capital | Minority |
Rand Bioscience FAQs
-
When was Rand Bioscience founded?
Rand Bioscience was founded in 2015.
-
Where is Rand Bioscience headquartered?
Rand Bioscience is headquartered in Daejeon, South Korea.
-
What is the size of Rand Bioscience?
Rand Bioscience has 6 total employees.
-
What industry is Rand Bioscience in?
Rand Bioscience’s primary industry is Drug Discovery.
-
Is Rand Bioscience a private or public company?
Rand Bioscience is a Private company.
-
What is Rand Bioscience’s current revenue?
The current revenue for Rand Bioscience is .
-
How much funding has Rand Bioscience raised over time?
Rand Bioscience has raised $13.2M.
-
Who are Rand Bioscience’s investors?
Ontide, Shinhan Venture Investment, C&R Research, Emford Equity Partners, and KB Investment are 5 of 8 investors who have invested in Rand Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process